HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thrombocytopenia after gemtuzumab is reversible by intravenous immunoglobulin.

AuthorsA Y H Leung, R Liang
JournalLeukemia (Leukemia) Vol. 19 Issue 6 Pg. 1077-8 (Jun 2005) ISSN: 0887-6924 [Print] England
PMID15815714 (Publication Type: Case Reports, Letter)
Chemical References
  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Immunoglobulins, Intravenous
  • Gemtuzumab
Topics
  • Aged
  • Aminoglycosides (adverse effects)
  • Antibodies, Monoclonal (adverse effects)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (adverse effects)
  • Gemtuzumab
  • Humans
  • Immunoglobulins, Intravenous
  • Leukemia, Myeloid, Acute (drug therapy)
  • Male
  • Thrombocytopenia (chemically induced, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: